-
June 4, 2009
Green tea ingredient may fight incurable leukemia
NEW YORK (Reuters Health) - A chemical found in green tea may shrink lymph nodes and reduce white blood cell counts in patients with chronic lymphocytic leukemia (CLL), a new study in the Journal of Clinical Oncology shows.
-
May 29, 2009
FDA advisers back Glaxo, Genmab cancer drug
ORLANDO, Florida (Reuters) - A small trial of Arzerra, being developed by GlaxoSmithKline Plc and Genmab for treating chronic lymphocytic leukemia, indicated benefits sufficient for U.S. approval, an advisory committee to regulators said on Friday.
-
May 27, 2009
FDA staff questions data on leukemia drug
WASHINGTON (Reuters) - U.S. drug reviewers questioned whether a proposed leukemia drug from GlaxoSmithKline PLC and Genmab provides enough benefit to warrant approval, documents released on Wednesday said.
-
February 4, 2009
Celiac disease linked to high risk of lymphoma
NEW YORK (Reuters Health) - Analysis of data from a Swedish cancer registry shows a more than 5-fold increased risk of non-Hodgkin lymphoma in patients with celiac disease, but the risk is steadily decreasing, and is less than half of what it was 40 years ago.
-
January 2, 2009
Cough medicine ingredient may treat prostate cancer
NEW YORK (Reuters Health) - Noscapine, a natural substance found in cough medicine, may prove useful in treating advanced prostate cancer, according to studies in mice.
-
December 8, 2008
Genentech drug boosts leukemia patient survival
LOS ANGELES (Reuters) - A combination of Genentech Inc's cancer drug Rituxan and chemotherapy reduces by 41 percent the risk of death or cancer progression, compared with chemotherapy alone, for patients with a common form of leukemia, the company said on Saturday.
-
November 21, 2008
Drug can extend leukaemia patients' lives: study
ZURICH (Reuters) - Roche Holding AG said on Friday its top-selling cancer drug MabThera helped patients with Chronic Lymphocytic Leukaemia (CLL) to live longer without their disease getting worse, according to a second late-stage study.
-
June 13, 2008
Hair dye may boost lymphoma risk: study
NEW YORK (Reuters Health) - A new study suggests that use of hair dye may increase the risk of certain types of non-Hodgkin lymphoma (NHL), a blood cancer involving the lymph nodes.
-
March 21, 2008
Cephalon wins U.S. approval for leukemia drug
WASHINGTON (Reuters) - Cephalon Inc won U.S. approval to sell a chemotherapy drug to treat patients with a slow-growing type of leukemia, the company said on Thursday.
-
December 10, 2007
Experimental drug works in type of leukemia
NEW YORK (Reuters) - Cephalon Inc's experimental cancer drug Treanda was significantly more effective than a common chemotherapy agent in helping patients with chronic lymphocytic leukemia (CLL) who had not received prior treatment achieve remission, according to a late-stage study.
-
October 31, 2007
Loss of viral control tied to lymphoma risk
NEW YORK (Reuters Health) - Patients who have abnormal reactive blood patterns when exposed to Epstein-Barr virus appear to have an increased risk of lymphoma, according to European researchers.